ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB.

Saved in:
Bibliographic Details
Title: ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB.
Authors: Voigt E; Access to Advanced Health Institute, Seattle, WA, United States., Alsharaydeh A; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, United States., Kasal DN; Access to Advanced Health Institute, Seattle, WA, United States., Jennewein MF; Access to Advanced Health Institute, Seattle, WA, United States., Brandt DS; Access to Advanced Health Institute, Seattle, WA, United States., Lin S; Access to Advanced Health Institute, Seattle, WA, United States., Singh J; Access to Advanced Health Institute, Seattle, WA, United States., Bakken J; Access to Advanced Health Institute, Seattle, WA, United States., Mohamath R; Access to Advanced Health Institute, Seattle, WA, United States., Fusco P; Access to Advanced Health Institute, Seattle, WA, United States., Torrelles JB; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, United States.; International Center for the Advancement of Research & Education (I·CARE), Texas Biomedical Research Institute, San Antonio, TX, United States., Beamer G; Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, United States.; International Center for the Advancement of Research & Education (I·CARE), Texas Biomedical Research Institute, San Antonio, TX, United States., Fox CB; Access to Advanced Health Institute, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States.
Source: Frontiers in immunology [Front Immunol] 2026 May 01; Vol. 17, pp. 1797767. Date of Electronic Publication: 2026 May 01 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1797767